Our collaborators at Charles River have launched the joint service offering through their website, combining the CRL Tumor Model Compendium (PDX in vitro, ex vivo, cell lines) with Cypre’s 3D Tumor Model Platform to deliver translationally relevant 3D assays for cancer drug discovery.

‍